Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$363M |
| 2 |
Nike
NKE
|
+$289M |
| 3 |
Home Depot
HD
|
+$271M |
| 4 |
Mastercard
MA
|
+$180M |
| 5 |
Amazon
AMZN
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$226M |
| 2 |
Coca-Cola
KO
|
+$225M |
| 3 |
Meta Platforms (Facebook)
META
|
+$205M |
| 4 |
Johnson & Johnson
JNJ
|
+$199M |
| 5 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$185M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.84% |
| 2 | Healthcare | 12.18% |
| 3 | Financials | 11.43% |
| 4 | Industrials | 9.05% |
| 5 | Consumer Discretionary | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
DLH Holdings
DLHC
$68.7M
| $383K | ﹤0.01% |
75,775
+5,700
| +8% | +$24.4K |
|
|
BSTG
2877
DELISTED
Biostage, Inc. Common Stock
BSTG
| $383K | ﹤0.01% |
336,400
-49,000
| -13% | -$79K |
|
2878
Universal Corp
UVV
$1.12B
| $381K | ﹤0.01% |
+6,600
| New | +$364K |
|
2879
Arrow Electronics
ARW
$10.6B
| $378K | ﹤0.01% |
+6,100
| New | +$387K |
|
2880
M/I Homes
MHO
$3.9B
| $375K | ﹤0.01% |
19,900
-38,300
| -66% | -$722K |
|
|
AINC
2881
DELISTED
Ashford Inc.
AINC
| $374K | ﹤0.01% |
+7,480
| New | +$368K |
|
|
ENG
2882
DELISTED
ENGlobal Corp
ENG
| $374K | ﹤0.01% |
38,988
+1,650
| +4% | +$15.9K |
|
|
XBKS
2883
DELISTED
Xenith Bankshares, Inc. Common Stock
XBKS
| $372K | ﹤0.01% |
20,776
+1,126
| +6% | +$19.8K |
|
2884
Performance Shipping
PSHG
$21.5M
| – | – |
0
| – | – |
|
|
SAFE
2885
Safehold
SAFE
$1.1B
| $368K | ﹤0.01% |
+7,889
| New | +$371K |
|
2886
Alphatec Holdings
ATEC
$1.51B
| $366K | ﹤0.01% |
87,150
+13,067
| +18% | +$36.2K |
|
|
VSR
2887
DELISTED
Versar, Inc.
VSR
| $365K | ﹤0.01% |
338,115
+12,015
| +4% | +$22.5K |
|
2888
Altimmune
ALT
$560M
| $364K | ﹤0.01% |
+497
| New | +$340K |
|
2889
Lantheus
LNTH
$6.59B
| $364K | ﹤0.01% |
+99,300
| New | +$228K |
|
|
USDP
2890
DELISTED
USD PARTNERS LP
USDP
| $364K | ﹤0.01% |
+37,800
| New | +$369K |
|
2891
MarketAxess Holdings
MKTX
$5.72B
| $363K | ﹤0.01% |
2,500
-104,200
| -98% | -$13.9M |
|
2892
Rush Enterprises Class A
RUSHA
$9.62B
| $362K | ﹤0.01% |
37,800
-297,401
| -89% | -$2.63M |
|
2893
Amtech Systems
ASYS
$280M
| $361K | ﹤0.01% |
60,436
+4,600
| +8% | +$29.2K |
|
2894
Kodak
KODK
$978M
| $359K | ﹤0.01% |
22,300
-48,400
| -68% | -$626K |
|
2895
Limoneira
LMNR
$250M
| $359K | ﹤0.01% |
20,400
-2,300
| -10% | -$38.2K |
|
|
NBIS
2896
Nebius Group N.V.
NBIS
$69.3B
| $358K | ﹤0.01% |
16,400
-1,382,600
| -99% | -$26.9M |
|
|
EMAN
2897
DELISTED
eMagin Corporation
EMAN
| $358K | ﹤0.01% |
186,700
+7,000
| +4% | +$12.9K |
|
|
STML
2898
DELISTED
Stemline Therapeutics, Inc.
STML
| $358K | ﹤0.01% |
52,900
-26,200
| -33% | -$165K |
|
|
HWCC
2899
DELISTED
Houston Wire & Cable Company
HWCC
| $357K | ﹤0.01% |
68,000
-4,600
| -6% | -$28.1K |
|
|
PLXP
2900
DELISTED
PLx Pharma Inc. Common Stock
PLXP
| $355K | ﹤0.01% |
4,475
+1,237
| +38% | +$107K |
|
Similar funds
Jim Simons's Q2 2016 Portfolio in Review
As of Q2 2016, Jim Simons held 3,774 positions worth $52.5B, down 0.13% from $52.6B the previous quarter. Its ten largest holdings account for 8% of the portfolio.
Jim Simons withdrew a net $1.64B in Q2 2016, closing 474 positions and reducing 1,158 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Jim Simons opened a new position in Nike worth $280M.
- Jim Simons's largest Q2 2016 buy was Nike: 5,066,500 shares worth $280M.
- Jim Simons added most to CVS Health in Q2 2016, an estimated $363M increase.
- Jim Simons's biggest Q2 2016 reduction was PepsiCo, cutting an estimated $226M.
- Jim Simons fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $185M.
- Jim Simons's ten largest holdings make up 8% of its $52.5B portfolio in Q2 2016.
- Jim Simons opened 423 new positions and closed 474 in Q2 2016.
- Jim Simons's portfolio value fell 0.13% quarter-over-quarter to $52.5B.
Based on Renaissance Technologies's 13F filing for Q2 2016, filed 12 Aug 2016.